VINC Valuation

Vincerx Pharma Inc

Add to Watchlist

Advanced Chart

0.000

-0.1(-100.000%)1D

Overview
Forecast
Valuation
Earnings

VINC Relative Valuation

VINC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, VINC is overvalued; if below, it's undervalued.

Historical Valuation

Vincerx Pharma Inc (VINC) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -0.73. The fair price of Vincerx Pharma Inc (VINC) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：0.06

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.23

P/B

Median3y

-2.83

Median5y

-82.01

-1948.29

FCF Yield

Median3y

-308.08

Median5y

-200.07

Competitors Valuation Multiple

The average P/S ratio for VINC's competitors is 0.61, providing a benchmark for relative valuation. Vincerx Pharma Inc Corp (VINC) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap